These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Effect of probiotics on intestinal barrier function. Mennigen R; Bruewer M Ann N Y Acad Sci; 2009 May; 1165():183-9. PubMed ID: 19538305 [TBL] [Abstract][Full Text] [Related]
26. Probiotics: The scientific evidence in the context of inflammatory bowel disease. Celiberto LS; Bedani R; Rossi EA; Cavallini DC Crit Rev Food Sci Nutr; 2017 Jun; 57(9):1759-1768. PubMed ID: 25996176 [TBL] [Abstract][Full Text] [Related]
27. What you must know before you recommend a probiotic. Clauson ER; Crawford P J Fam Pract; 2015 Mar; 64(3):151-5. PubMed ID: 25789349 [TBL] [Abstract][Full Text] [Related]
28. What is the evidence for the use of probiotics in the treatment of inflammatory bowel disease? Cary VA; Boullata J J Clin Nurs; 2010 Apr; 19(7-8):904-16. PubMed ID: 20492035 [TBL] [Abstract][Full Text] [Related]
29. Probiotics in inflammatory bowel disease: new insight to pathogenesis or a possible therapeutic alternative? Campieri M; Gionchetti P Gastroenterology; 1999 May; 116(5):1246-9. PubMed ID: 10220518 [No Abstract] [Full Text] [Related]
30. A natural approach to treatment of inflammatory bowel disease. Guslandi M Br J Clin Pharmacol; 2008 Apr; 65(4):468-9. PubMed ID: 18333859 [No Abstract] [Full Text] [Related]
31. Clinical usefulness of probiotics in inflammatory bowel diseases. Mach T J Physiol Pharmacol; 2006 Nov; 57 Suppl 9():23-33. PubMed ID: 17242485 [TBL] [Abstract][Full Text] [Related]
32. Review of the role of probiotics in gastrointestinal diseases in adults. Sebastián Domingo JJ Gastroenterol Hepatol; 2017; 40(6):417-429. PubMed ID: 28185664 [TBL] [Abstract][Full Text] [Related]
33. Probiotics and intestinal inflammatory disorders in infants and children. Vanderhoof JA J Pediatr Gastroenterol Nutr; 2000; 30 Suppl 2():S34-8. PubMed ID: 10749399 [No Abstract] [Full Text] [Related]
34. [New therapies of chronic inflammatory bowel disease: anti-TNF antibodies and probiotics. The Danish Society of Gastroenterology]. Kjeldsen J; Brynskov J; Madsen JR Ugeskr Laeger; 2001 Mar; 163(12):1707. PubMed ID: 11284407 [No Abstract] [Full Text] [Related]
35. Probiotics in inflammatory bowel disease: a critical review. Tamboli CP; Caucheteux C; Cortot A; Colombel JF; Desreumaux P Best Pract Res Clin Gastroenterol; 2003 Oct; 17(5):805-20. PubMed ID: 14507590 [TBL] [Abstract][Full Text] [Related]
38. [Probiotics in gastrointestinal pathology]. Cijevschi C; Rezmireş A; Mihai C; Miuţescu E Rev Med Chir Soc Med Nat Iasi; 2002; 107(2):264-7. PubMed ID: 12638270 [TBL] [Abstract][Full Text] [Related]
39. Probiotics: Isolated bacteria strain or mixtures of different strains? Two different approaches in the use of probiotics as therapeutics. Karimi O; Pena AS Drugs Today (Barc); 2003 Aug; 39(8):565-97. PubMed ID: 14566382 [TBL] [Abstract][Full Text] [Related]
40. Targeting intestinal microflora in inflammatory bowel disease. Guslandi M World J Gastroenterol; 2006 Nov; 12(44):7225-6. PubMed ID: 17131494 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]